AnaptysBio, Inc. (ANAB) Earnings
|
Expand Research on ANAB
| Next EPS Date | 11/10/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | $0.11 | N/A | N/A | $17.51M | N/A | N/A | N/A | ||
| 8/31/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/28/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/26/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/25/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/24/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/21/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/19/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A |
